Jyrki Mattila Insider Trading $LPCN Lipocine Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jyrki Mattila.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jyrki Mattila. Jyrki Mattila is Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Executive Vice President in AUXILIUM PHARMACEUTICALS INC ($AUXL) and Chief Business Officer in Lipocine Inc. ($LPCN) and Executive VP, Business Dev. in Recro Pharma, Inc. ($REPH).
Jyrki Mattila in Lipocine Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jyrki Mattila: Chief Business Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 30 2017
$LPCN Market Capitalization: $68.11M
$LPCN Previous Close: $3.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jyrki Mattila in Lipocine Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AUXL, BSTCE, LPCN, REPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2017 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Dec 08 2016 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 3.61 | 40,000 | 144,400 | 40,000 | |
| Jan 07 2016 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 12.92 | 40,000 | 516,800 | 40,000 | |
| Jun 15 2015 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 7.32 | 10,000 | 73,200 | 90,000 | |
| May 18 2015 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 7.66 | 80,000 | 612,800 | 80,000 |
Page: 1